TITLE

Antipneumococcal Activity of Moxifloxacin

AUTHOR(S)
Dalhoff, A.
PUB. DATE
December 1999
SOURCE
Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p351
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the development of 8-methoxyquinolone, moxifloxacin, with enhanced Gram-positive activity and an extended spectrum of activity including Mycoplasma spp., Chlamydia spp. and other atypicals. Materials and methods; Results.
ACCESSION #
9593572

 

Related Articles

  • Inhibitory activity of garenoxacin against DNA gyrase of Mycoplasma pneumoniae. Nakatani, Masatoshi; Mizunaga, Shingo; Takahata, Masahiro; Nomura, Nobuhiko // Journal of Antimicrobial Chemotherapy (JAC);Aug2012, Vol. 67 Issue 8, p1850 

    Objectives Garenoxacin, a des-fluoro(6)-quinolone, exhibits potent activity against Mycoplasma pneumoniae, including macrolide-resistant strains. There has been no report on the inhibitory activity of garenoxacin against the target enzyme of M. pneumoniae. Methods Subunits of DNA gyrase (GyrA...

  • Doxycycline failure in lymphogranuloma venereum. Méchaï, Frédéric; De Barbeyrac, Bertille; Aoun, Olivier; Mérens, Audrey; Imbert, Patrick; Rapp, Christophe // Sexually Transmitted Infections;Aug2010, Vol. 86 Issue 4, p9 

    Lymphogranuloma venereum (LGV) cases are currently re-emerging in the homosexual community, particularly in HIV-seropositive patients. The standard treatment for this infection, which is caused by Chlamydia trachomatis L1, L2 and L3 serotypes, is a 3-week doxycycline regimen. The case is...

  • Interaction Profile of Moxifloxacin. Stass, H.; Kubitza, D. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p235 

    Investigates the influence of probenecid on the elimination of moxifloxacin. Methods; Results.

  • Activity of Newer Fluoroquinolones In Vitro Against Gram-Positive Bacteria. Eliopoulos, G.M. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p23 

    Several newer fluoroquinolones, which have been recently introduced or are under investigation, display substantially greater potency against Gram-positive organisms than the older generation agents of this class. Nevertheless, for problem organisms including methicillin-resistant strains of...

  • erythromycin.  // Royal Society of Medicine: Medicines;2002, p233 

    The article presents information on erythromycin, an antibacterial and antibiotic drug which is an original member of the macrolide group. Erythromycin has a similar spectrum of action similar to penicillin, but acts in a different way. It is effective against many Gram-positive bacteria...

  • Moxifloxacin.  // Reactions Weekly;Sep2015, Vol. 1568 Issue 1, p202 

    The article presents a case study of a 78-year-old male patient who developed acute confusional syndrome during moxifloxacin treatment.

  • Moxifloxacin: Comparative Inhibitory Bactericidal Activity Against Susceptible and Multidrug-Resistant Gram-Positive Bacteria. Speciale, A.; Aleo, G.; La Ferla, K.; Musumeci, R.; Caccamo, F.; Nicoletti, G. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p156 

    Assesses the in vitro activity of moxifloxacin against selected strains of Gram-positive bacteria and some strains with a difference resistance pattern. Materials and methods; Information on the minimum inhibitory concentration; Data on killing curves.

  • Activities of Quinolones Against Obligately Anaerobic Bacteria. Schaumann, R.; Rodloff, A. C. // Anti-Infective Agents in Medicinal Chemistry;2007, Vol. 6 Issue 1, p49 

    Quinolones are of clinical and scientific interest since their discovery based on the nalidixic acid in the early 1960s. They are based on two types of ring structures, the quinolone nucleus and the naphthyridone nucleus. Nalidixic acid as the first discovered agent is a naphthyridone and has...

  • Structural Features of New Quinolones and Relationship to Antibacterial Activity Against Gram-positive Bacteria. Emami, Saeed; Shafiee, Abbas; Foroumadi, Alireza // Mini Reviews in Medicinal Chemistry;Apr2006, Vol. 6 Issue 4, p375 

    A major recent focus of quinolone antibacterials has been the development of agents with enhanced activity against Gram-positive bacteria. The extensive research efforts have enabled a better definition of the structural features of quinolones that offer the best combination of clinical efficacy...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics